autologous anti-CD19 CAR-CD28 T cells ET019002
Term · Oncology and biomedicine · MLC-T-ONC-011360
A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) consisting of a single chain variable fragment (scFv) of anti-CD19, coupled to the costimulatory domain of CD28, with potential immunostimulating and antineoplastic activities. Upon transfusion, the autologous anti-CD19 CAR-CD28 T cells ET019002 target, bind to, and induce selective toxicity in CD19-expressing B cells. The CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.
| Identifier | MLC-T-ONC-011360 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD19 autologous CAR T cells ET019002; ET019002-T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011360",
"term": "autologous anti-CD19 CAR-CD28 T cells ET019002",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) consisting of a single chain variable fragment (scFv) of anti-CD19, coupled to the costimulatory domain of CD28, with potential immunostimulating and antineoplastic activities. Upon transfusion, the autologous anti-CD19 CAR-CD28 T cells ET019002 target, bind to, and induce selective toxicity in CD19-expressing B cells. The CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.",
"synonyms": [
"anti-CD19 autologous CAR T cells ET019002",
"ET019002-T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-cd19-car-cd28-t-cells-et019002/"
}
Record 2,692 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.